Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment

BMC Pediatrics

Volumn 16, Issue 1, 2016, Pages

  Hicks, Steven D ^a   Ignacio, Cherry ^b   Gentile, Karen ^c   Middleton, Frank A ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Partek Inc   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Biomarker; MiRNA; Next generation sequencing; RNA Seq; Saliva

Indexed keywords

MICRORNA; MICRORNA 127 3P; MICRORNA 140 3P; MICRORNA 191 5P; MICRORNA 218 5P; MICRORNA 23 3P; MICRORNA 2467 5P; MICRORNA 28 5P; MICRORNA 30E 5P; MICRORNA 32 5P; MICRORNA 335 3P; MICRORNA 3529 5P; MICRORNA 628 5P; MICRORNA 7 5P; UNCLASSIFIED DRUG; GENETIC MARKER;

ADAPTIVE BEHAVIOR; ARTICLE; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; CHILD; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DSM-5; EPIGENETICS; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; NERVE CELL DIFFERENTIATION; NEXT GENERATION SEQUENCING; PREMATURITY; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA SEQUENCE; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; ADOLESCENT; AUTISM SPECTRUM DISORDER; BRAIN; CASE CONTROL STUDY; CHEMISTRY; CHILD DEVELOPMENT; CLINICAL TRIAL; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PRESCHOOL CHILD; PSYCHOLOGY; SALIVA; STATISTICAL MODEL;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; AUTISM SPECTRUM DISORDER; BRAIN; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPIGENESIS, GENETIC; FEMALE; GENETIC MARKERS; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MONTE CARLO METHOD; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 84963956756     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-016-0586-x     Document Type: Article

References (28)

1. Harrington JW, Allen K. The Clinician's guide to autism. Pediatr Rev. 2014;35:62-77.
2. Wetherby AM, Brosnan-Maddox S, Peace V, Newton L. Validation of the Infant-Toddler Checklist as a broadband screener for autism spectrum disorders from 9 to 24 months of age. Autism. 2008;12:487-511.
3. Robins DL. Screening for autism spectrum disorders in primary care settings. Autism. 2008;12:537-56.
4. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163:907-14.
5. Constantino JN, Todorov A, Hilton C, Law P, Zhang Y, Molloy E, Fitzgerald R, Geschwind D. Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD. Mol Psychiatry. 2013;18:137-8.
6. Xu LM, Li JR, Huang Y, Zhao M, Tang X, Wei L. Autism: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res. 2012;40:D1016-22.
7. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet. 2012;3:1-9.
8. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva are concentrated in exosomes. PLoS One. 2012;7:e30679.
9. Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS. Heterogeneous dysregulation of microRNAs across autism spectrum. Neurogenetics. 2008;9:153-61.
10. Talebizadeh Z, Butler MG, Theodoro MF. Feasability and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res. 2008;1:1-11.
11. Sarachana T, Zhou R, Chen G, Manji HK, Hu VW. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2010;2:23.
12. Ghahramani-Seno MM, Hu P, Gwadry FG, Pinto D, Marshall CR, Casallo G, Scherer SW. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res. 2011;1380:85-97.
13. Vasu MM, Anitha A, Thanseem I, Suzuki K, Yamada K, Takahashi T, Wakuda T, Iwata K, Tsujii M, Sugiyama T, Mori N. Serum microRNA profiles in children with autism. Mol Autism. 2014;5:40.
14. Ziats MN, Rennert OM. Identification of differentially expressed microRNAs across developing human brain. Mol Psychiatry. 2014;19:848-52.
15. Shao NY, Hu HY, Xu Y, Hu H, Menzel C, Li N, Chen W, Khaitovich P. Comp-rehensive survey of human brain microRNA by deep sequencing. BMC Genomics. 2010;11:409.
16. Banerjee-Basu S, Packer A. SFARI Gene: an evolving database for the autism research community. Dis Model Mech. 2010;3:133-5.
17. Daniels AM, Halladay AK, Shih A, Elder LM, Dawson G. Approaches to enhancing the early detection of autism spectrum disorders: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2014;53:141-52.
18. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A. 1997;94(10):5395-400.
19. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, Nelson DL, Moses K, Warren ST. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004;7:113-7.
20. MacDermot KD, Bonora E, Sykes N, Coupe AM, Lai CSL, Vernes SC, Vargha-Khadem F, McKenzie F, Smith RL, Monaco AP, Fisher SE. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. AJHG. 2005;76(5):1074-80.
21. Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the micro-RNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer. 2010;9:232.
22. Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, Xu H, Jiang S. miR-24-3p and MiR27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol. 2012;42:757-66.
23. Siefel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci U S A. 2011;108:11662-7.
24. Song Y, Tian X, Zhang S, Zhang Y, Li X, Li D, Cheng Y, Zhang J, Kang C, Zhao W. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res. 2011;1387:134-40.
25. Li Y, Xu J, Chen H, Li S, Zhao Z, Shao T, Jiang T, Ren H, Kang C, Li X. Compre-hensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression. Nucleic Acids Res. 2013;41:e203.
26. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, Thiruvahindrapuram B, Xu X, Ziman R, Cook EH, Buxbaum JD, Devlin B, Gallagher L, Betancur C, Scherer SW. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014;94:677-94.
27. Geschwind DH. Genetics of autism spectrum disorder. Trends Cog Sci. 2011;15:409-16.
28. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill S, Stevens CR, Schubert CR, Greenberg ME, Gabriel SB, Walsh CA. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 2012;8(4):e1002635.